Research Solutions, Inc.
Research Solutions, Inc. provides cloud-based research intelligence software and transactional content-delivery services for scientific and technical information. The company serves customers through its Article Galaxy platform and related tools, helping users discover, manage, and obtain scholarly articles and other STM content.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueSubscription access to cloud-based research intelligence and workflow software, including premium platform features.
Transactional delivery of STM articles and related copyright/service fees charged per order.
Products
Reported · share of revenue- Transactions56.9 %
- Platforms43.1 %
Source: 10-K FY2026, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Customers include life science companies, academic institutions, and other research-intensive organizations that need fast access to scholarly and technical content. The company also sells to corporate libraries and non-library buyers in R&D and other business functions, especially in pharmaceutical, biotechnology, and medical device markets. Customers buy the service to reduce internal workflow burden, improve access to licensed content, and simplify copyright-compliant article delivery.
Pharmaceutical, biotechnology, and medical device customers use the platform for research content access, workflow efficiency, and collaboration.
Universities and research libraries buy article delivery and content access services for faculty and researchers.
Enterprise library teams use the platform to manage subscriptions, authentication, and compliant content reuse.
Scientists and business-function users buy direct access to articles and AI-enabled research tools.
Aerospace, automotive, electronics, chemicals, and food/agriculture customers use the service for technical research.
Strategy
The company’s strategy centers on expanding its research workflow platform, cross-selling software into existing customers, and adding new interactive and AI-enabled tools. It also targets growth through direct sales, channel relationships, RFP-driven enterprise wins, and broader penetration of underserved small and medium-sized businesses. Product development and acquisitions are used to broaden the service portfolio and deepen customer value.
Raises value per customer and deepens workflow integration.
Diversifies demand beyond core life sciences and libraries.
Improves customer acquisition efficiency and market coverage.
Keeps the platform relevant in research workflow software.
Geography
Q1/2026Research Solutions is based in the United States and serves customers globally through its digital platform and publisher network. The business depends on access to content publishers and research customers across multiple end markets, with demand tied more to research activity than to any single country. Its service model is internet-based, so geography matters mainly through customer location, publisher relationships, and compliance requirements.
Share of the revenue the company reports by geography.
Risks
The business depends on reliable software, secure data handling, and continued access to publisher content, so cybersecurity, privacy, and compliance failures could disrupt service and damage trust. It also faces competition from in-house customer solutions, publisher-owned tools, reference management apps, and piracy, which can pressure demand for paid content delivery. AI adoption adds both opportunity and risk because it can expose confidential information, create new security issues, and intensify competition.
- Cybersecurity and IT system disruptionImpact: HighLikelihood: Medium
The platform depends on reliable networks and secure access to customer and publisher data.
Exposure - GenAI-related confidentiality and compliance exposureImpact: HighLikelihood: Medium
AI tools may process sensitive customer or proprietary information and create new security risks.
Exposure - Piracy and copyright non-complianceImpact: HighLikelihood: Low
Unauthorized use of STM content can bypass paid transactional delivery and copyright fees.
Exposure: Transactions revenue
- Competition from publisher and reference toolsImpact: MediumLikelihood: Medium
Alternative tools can reduce the need for third-party aggregation and workflow software.
Exposure: Market share and pricing
- Customer in-house substitutionImpact: MediumLikelihood: Low
Some customers can build or retain internal article delivery and workflow capabilities.
Exposure: Platform and transaction demand
Accounting
Judgemental itemsPlatform subscriptions and transactional delivery are recognized differently, affecting timing of revenue.
Impact: Revenue timing, deferred revenue, quarterly comparability
Advance billings for subscriptions create a liability until services are delivered.
Impact: Working capital and revenue smoothing
Acquisition-related earn-out estimates are remeasured using valuation assumptions.
Impact: Earnings volatility and balance-sheet fair value changes
Acquisitions create goodwill that must be tested for impairment annually or upon triggering events.
Impact: Potential non-cash write-downs
Acquired software and customer-related intangibles may require impairment assessment.
Impact: Amortization and possible impairment charges
Similar listed companies
Publicly listed companies with a comparable business focus.
FactSet Research Systems Inc
FDS · Services-Computer Programming, Data Processing, Etc.
UL Solutions Inc.
ULS · Services-Testing Laboratories
Penguin Solutions, Inc.
PENG · Semiconductors & Related Devices
Clarivate Plc
CLVT · Services-Computer Processing & Data Preparation
Clarivate Plc is a Jersey-incorporated information and analytics company whose business centers on helping customers manage research, innovation, and intellectual property workflows.
Artificial Intelligence Technology Solutions Inc.
AITX · Services-Prepackaged Software
Recursion Pharmaceuticals, Inc
RXRX · Biological Products, (No Diagnostic Substances)
Recursion Pharmaceuticals is a U.S.-based clinical-stage TechBio company that uses its Recursion Operating System to discover and develop medicines.
Last updated: 24/09/2026